期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Transplantation of vascular endothelial growth factor-modified neural stem/progenitor cells promotes the recovery of neurological function following hypoxic-ischemic brain damage 被引量:12
1
作者 yue Yao Xiang-rong Zheng +4 位作者 Shan-shan Zhang Xia Wang xiao-he yu Jie-lu Tan yu-jia Yang 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第9期1456-1463,共8页
Neural stem/progenitor cell (NSC) transplantation has been shown to effectively improve neurological function in rats with hypoxic-isch- emic brain damage. Vascular endothelial growth factor (VEGF) is a signaling ... Neural stem/progenitor cell (NSC) transplantation has been shown to effectively improve neurological function in rats with hypoxic-isch- emic brain damage. Vascular endothelial growth factor (VEGF) is a signaling protein that stimulates angiogenesis and improves neural regeneration. We hypothesized that transplantation of VEGF-transfected NSCs would alleviate hypoxic-ischemic brain damage in neo- natal rats. We produced and transfected a recombinant lentiviral vector containing the VEGF165gene into cultured NSCs. The transfected NSCs were transplanted into the left sensorimotor cortex of rats 3 days after hypoxic-ischemic brain damage. Compared with the NSCs group, VEGF mRNA and protein expression levels were increased in the transgene NSCs group, and learning and memory abilities were significantly improved at 30 days. Furthermore, histopathological changes were alleviated in these animals. Our findings indicate that transplantation of VEGF-transfected NSCs may facilitate the recovery of neurological function, and that its therapeutic effectiveness is better than that of unmodified NSCs. 展开更多
关键词 nerve regeneration vascular endothelial growth factor TRANSFECTION neural stem/progenitor cells TRANSPLANTATION hypoxic-ischemicbrain damage cerebral cortex animal model NEUROPROTECTION neural regeneration
下载PDF
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by pembrolizumab: A case report 被引量:1
2
作者 xiao-he yu Jian Huang +2 位作者 Nai-Jian Ge Ye-Fa Yang Jin-Yan Zhao 《World Journal of Clinical Cases》 SCIE 2021年第10期2281-2288,共8页
BACKGROUND Undifferentiated embryonal sarcoma of the liver(UESL)is a neoplasm that rarely develops in adults.The main treatments for UESL are upfront gross total surgical resection and adjuvant multiagent chemotherapy... BACKGROUND Undifferentiated embryonal sarcoma of the liver(UESL)is a neoplasm that rarely develops in adults.The main treatments for UESL are upfront gross total surgical resection and adjuvant multiagent chemotherapy.Here,we report a case of recurrent UESL in an adult treated with pembrolizumab and discuss a method to identify proper candidates for antibody of programmed cell death protein 1(anti-PD-1)treatment.CASE SUMMARY A 69-year-old woman was admitted for abdominal pain that developed for 1 wk.Computed tomography showed a 16 cm mass in the right lobe of the liver.Right hemihepatectomy and lymphadenectomy were performed,and histological diagnosis was UESL.Six months later,the patient suffered from painless obstructive jaundice,and positron emission tomography-computed tomography revealed multiple metastases.Then,percutaneous transhepatic cholangial drainage was applied to reduce jaundice,and radiofrequency ablation was used to control the lesion near the hepatic hilum.However,the patient suffered from a serious fever caused by the tumor.The patient received treatment with pembrolizumab,and the prescribed dosage was 2 mg/kg every 3 wk.After the seventh dose,positron emission tomography-computed tomography revealed that the multiple metastases had nearly disappeared.Radiologic exam was used to evaluate the disease state,and no new lesions were found.Next-generation sequencing and immunohistology were applied to determine the reason why the patient had such a favorable response to pembrolizumab.Tumor mutation burden,microsatellite instability,and programmed death ligand 1 expression can be combined to predict the effect of PD-1 antibodies. When every one of thesebiomarkers are detected in a tumor patient, the patient may be a proper candidatefor PD-1 antibodies.CONCLUSION Anti-PD-1 treatment for tumors needs further research to identify indications andproper biomarkers. 展开更多
关键词 Undifferentiated embryonal sarcoma of the liver Pembrolizumab Programmed cell death protein 1 Tumor mutation burden IMMUNOHISTOLOGY Case report
下载PDF
How online ADHD-related information affects Chinese parents' decisions? 被引量:2
3
作者 xiao-he yu Le Zhong Jia Huang 《World Journal of Pediatrics》 SCIE CAS CSCD 2019年第1期57-65,共9页
Background Attention deficit hyperactivity disorder (ADHD) is a major public health problem in China.Parents of children with confirmed,or suspected ADHD often face a difficult process in making decisions concerning d... Background Attention deficit hyperactivity disorder (ADHD) is a major public health problem in China.Parents of children with confirmed,or suspected ADHD often face a difficult process in making decisions concerning diagnosis and treatment.The internet is a major source of information for parents.The purpose of this study is to survey Chinese parental motivation and experience in using the internet to retrieve ADHD-related information,and how well online information is associated with making decisions.Methods Parents were recruited to fill out an online questionnaire in the health portal.A total of 404 valid questionnaires were collected.Results A total of 47.8% of parents agree that the internet helps them to understand the potential treatment options,but 77.7% of all parents still have conflict during decision-making.Conclusions Parents search for ADHD-related information online,but their acquisition skills need to be improved.Internet information affects their health decisions.Parents still have highly conflicting decision-making.Improving the ability of parents to obtain information on the Internet may reduce the conflict in decision-making. 展开更多
关键词 Attention DEFICIT HYPERACTIVITY disorder Decision-making CONFLICT PARENTS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部